LSE Health, London School of Economics and Political Science, London, UK.
Department of Obstetrics and Gynecology, College of Medicine of the University of Lagos, Lagos, Nigeria.
Int J Gynaecol Obstet. 2021 Feb;152(2):242-248. doi: 10.1002/ijgo.13436. Epub 2020 Nov 26.
To estimate utilization costs of spontaneous vaginal delivery (SVD) and cesarean delivery (CD) for pregnant women with coronavirus disease 2019 (COVID-19) at the largest teaching hospital in Lagos, the pandemic's epicenter in Nigeria.
We collected facility-based and household costs of all nine pregnant women with COVID-19 managed at the hospital. We compared their mean facility-based costs with those paid by pregnant women pre-COVID-19, identifying cost-drivers. We also estimated what would have been paid without subsidies, testing assumptions with a sensitivity analysis.
Total utilization costs ranged from US $494 for SVD with mild COVID-19 to US $4553 for emergency CD with severe COVID-19. Though 32%-66% of facility-based cost were subsidized, costs of SVD and CD during the pandemic have doubled and tripled, respectively, compared with those paid pre-COVID-19. Of the facility-based costs, cost of personal protective equipment was the major cost-driver (50%). Oxygen was the major driver for women with severe COVID-19 (48%). Excluding treatment costs for COVID-19, mean facility-based costs were US $228 (SVD) and US $948 (CD).
Despite cost exemptions and donations, utilization costs remain prohibitive. Regulation of personal protective equipment and medical oxygen supply chains and expansion of advocacy for health insurance enrollments are needed in order to minimize catastrophic health expenditure.
估算在尼日利亚拉各斯最大的教学医院,即新冠疫情的中心,患有 2019 冠状病毒病(COVID-19)的孕妇行自然分娩(SVD)和剖宫产(CD)的利用成本。
我们收集了在医院管理的 9 名 COVID-19 孕妇的所有基于机构和家庭的成本。我们比较了她们的平均机构成本与 COVID-19 前孕妇的支付成本,确定了成本驱动因素。我们还估算了没有补贴时的支付金额,并通过敏感性分析检验了假设。
SVD 的总利用成本从轻度 COVID-19 的 494 美元到严重 COVID-19 的紧急 CD 的 4553 美元不等。尽管 32%-66%的机构成本得到了补贴,但 COVID-19 期间 SVD 和 CD 的成本分别是 COVID-19 前的两倍和三倍。在机构成本中,个人防护设备的成本是主要的成本驱动因素(50%)。对于患有严重 COVID-19 的女性,氧气是主要的驱动因素(48%)。不包括 COVID-19 的治疗费用,SVD 的平均机构成本为 228 美元,CD 的平均机构成本为 948 美元。
尽管免除了费用和捐赠,但利用成本仍然过高。需要规范个人防护设备和医用氧气供应链,并扩大医疗保险参保的宣传力度,以尽量减少灾难性的医疗支出。